Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 2Phase 4 1

Status

Completed 4Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 14OTHER 7NIH 2

Study Type

Interventional 7

Sponsor

Cancer Type

Breast 4Tumor-Agnostic 2Gynecologic 1

Conditions

Breast Neoplasms 52Ovarian Neoplasms 40Multiple Myeloma 20Fallopian Tube Neoplasms 13Lymphoma 12Sarcoma 11Carcinoma, Ovarian Epithelial 11Triple Negative Breast Neoplasms 8Recurrence 8Lymphoma, Large B-Cell, Diffuse 8Neoplasms 7Lymphoma, Non-Hodgkin 7Hodgkin Disease 6Neoplasms, Plasma Cell 5Sarcoma, Ewing 4Prostatic Neoplasms 4Neoplasm Metastasis 4Lymphoma, Mantle-Cell 4Burkitt Lymphoma 4Rhabdomyosarcoma 3Osteosarcoma 3Lymphoma, T-Cell, Peripheral 3Leiomyosarcoma 3Breast Neoplasms, Male 3Uterine Cervical Neoplasms 2Solid Tumors 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, T-Cell 2

Interventions

Surveys and Questionnaires 114Exercise 103Blood Specimen Collection 99Radiotherapy 67Gemcitabine 64Bevacizumab 57Standard of Care 56Cisplatin 55Cyclophosphamide 51Capecitabine 50Carboplatin 49Docetaxel 47pembrolizumab 46Dexamethasone 46Paclitaxel 45Interviews as Topic 43Oxaliplatin 40Magnetic Resonance Spectroscopy 39Fluorouracil 37Methods 36Irinotecan 36Therapeutics 33Drug Therapy 33Radiosurgery 31Nivolumab 30Erlotinib Hydrochloride 27Educational Status 26Everolimus 24Leucovorin 23Control Groups 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
OTHER × Neoplasms × liposomal doxorubicin × Clear all
NCT03203525 2026-02-25

Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
38 enrolled
Tumor-Agnostic

Neoplasms

NCT03164993 2024-10-15

ALICE

Oslo University Hospital

Phase 2 Completed
68 enrolled
Breast

Breast Neoplasms, Neoplasms, Triple Negative Breast Neoplasms

NCT03409198 2024-10-15

ICON

Oslo University Hospital

Phase 2 Completed
82 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT00563953 2017-10-12

CAPRICE

SOLTI Breast Cancer Research Group

Phase 2 Completed
50 enrolled
Breast

Breast Neoplasms, Heart Diseases, Neoplasms

NCT00758732 2015-09-28

Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma

Hellenic Oncology Research Group

Phase 2 Terminated
34 enrolled
Gynecologic

Neoplasms, Ovarian Neoplasms

NCT00183742 2014-05-22

Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere)

University of Southern California

Phase 1 Completed
35 enrolled
Tumor-Agnostic

Carcinoma, Neoplasms

NCT00531973 2009-02-18

LITE

Catholic University, Italy

Phase 4 Unknown
80 enrolled
Breast

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡